Connors Investor Services Inc Catalyst Pharmaceuticals, Inc. Transaction History

Connors Investor Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$6.23 - $8.57 $31,150 - $42,850	-5,000 Reduced 14.07%	30,538 $214,000
Q1 2022 May 18, 2022	SELL	$5.31 - $8.31 $47,790 - $74,790	-9,000 Reduced 20.21%	35,538 $295,000
Q4 2021 Feb 15, 2022	SELL	$5.21 - $7.45 $78,150 - $111,750	-15,000 Reduced 25.19%	44,538 $302,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $53,460 - $68,940	18,000 Added 43.33%	59,538 $199,000
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $123,367 - $211,013	41,538 New	41,538 $123,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

Stay updated on Connors Investor Services Inc with notifications on news.